• Explore /
  • Poster
  • / Stereotactic body radiotherapy (SBRT) combined with transcatheter arterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) versus TACE and TKIs alone for unresectable hepatocellular carcinoma (uHCC) with portal vein tumor thrombus (PVTT): A randomized controlled trial.

Stereotactic body radiotherapy (SBRT) combined with transcatheter arterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) versus TACE and TKIs alone for unresectable hepatocellular carcinoma (uHCC) with portal vein tumor thrombus (PVTT): A randomized controlled trial.

Abstract Poster

Authors

null

Jiayu Duan

Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Jiayu Duan , Jitao Zhou , Chang Liu , Hanyu Jiang , Jin Zhou , Kunlin Xie , Hong Wu , Yong Zeng , Xin Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

ChiCTR1900025300

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4102)

DOI

10.1200/JCO.2024.42.16_suppl.4102

Abstract #

4102

Poster Bd #

82

Abstract Disclosures

Similar Posters

First Author: Claudia A.M. Fulgenzi

First Author: Xiaodong Wang

First Author: Jinpeng Li

First Author: Claudia A.M. Fulgenzi